Rising survival rates for AML patients over 65 after allogeneic hematopoietic stem cell transplant

  • Post author:
  • Post category:uncategorized

Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid leukemia (AML) between 2000 and 2021, leukemia-free and overall survival improved significantly over time.